Preservative-free treprostinil formulations and methods and devices for use with same
US10632129B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2015 |
| Grant date | Apr 28, 2020 |
| Priority date | — |
| Expiry date | Nov 15, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C405/0075
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides for a unit dosage form of treprostinil at a dosage of between 0.1 mg/mL and 25 mg/mL in a sterile fluid composition formulated for subcutaneous or intravenous injection, which composition does not comprise an antimicrobial preservative, and methods of reducing irritation, inflammation or a combination thereof at a site of subcutaneous or intravenous infusion of treprostinil in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.